NO20011545D0 - Anvendelse av 3-(1H-imidazol-4-yl-metyl)-indan-5-ol til fremstilling av et legemiddel for intraspinal, intratekal eller epidural administrering - Google Patents

Anvendelse av 3-(1H-imidazol-4-yl-metyl)-indan-5-ol til fremstilling av et legemiddel for intraspinal, intratekal eller epidural administrering

Info

Publication number
NO20011545D0
NO20011545D0 NO20011545A NO20011545A NO20011545D0 NO 20011545 D0 NO20011545 D0 NO 20011545D0 NO 20011545 A NO20011545 A NO 20011545A NO 20011545 A NO20011545 A NO 20011545A NO 20011545 D0 NO20011545 D0 NO 20011545D0
Authority
NO
Norway
Prior art keywords
indan
imidazol
intraspinal
intrathecal
medicament
Prior art date
Application number
NO20011545A
Other languages
English (en)
Other versions
NO20011545L (no
NO330436B1 (no
Inventor
Antti Haapalinna
Jyrki Lehtimaeki
Tiina Leino
Timo Viitamaa
Raimo Virtanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20011545D0 publication Critical patent/NO20011545D0/no
Publication of NO20011545L publication Critical patent/NO20011545L/no
Publication of NO330436B1 publication Critical patent/NO330436B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20011545A 1998-09-28 2001-03-26 Anvendelse av 3-(1H-imidazol-4-yl-metyl)-indan-5-ol og lignende til fremstilling av et legemiddel for intraspinal administrering for a oppna analgesi eller som et hjelpemiddel til anestesi NO330436B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10198698P 1998-09-28 1998-09-28
PCT/FI1999/000793 WO2000018400A1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Publications (3)

Publication Number Publication Date
NO20011545D0 true NO20011545D0 (no) 2001-03-26
NO20011545L NO20011545L (no) 2001-03-26
NO330436B1 NO330436B1 (no) 2011-04-11

Family

ID=22287519

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011545A NO330436B1 (no) 1998-09-28 2001-03-26 Anvendelse av 3-(1H-imidazol-4-yl-metyl)-indan-5-ol og lignende til fremstilling av et legemiddel for intraspinal administrering for a oppna analgesi eller som et hjelpemiddel til anestesi

Country Status (24)

Country Link
US (1) US6495584B1 (no)
EP (1) EP1117399B1 (no)
JP (1) JP4647785B2 (no)
KR (1) KR100646811B1 (no)
CN (1) CN1320034A (no)
AT (1) ATE288753T1 (no)
AU (1) AU756104B2 (no)
BG (1) BG105469A (no)
CA (1) CA2345521C (no)
CZ (1) CZ299918B6 (no)
DE (1) DE69923698T2 (no)
DK (1) DK1117399T3 (no)
EA (1) EA003216B1 (no)
EE (1) EE200100193A (no)
ES (1) ES2237205T3 (no)
HK (1) HK1039751A1 (no)
HU (1) HU227634B1 (no)
IL (2) IL141680A0 (no)
NO (1) NO330436B1 (no)
NZ (1) NZ510233A (no)
PL (1) PL346908A1 (no)
SK (1) SK3812001A3 (no)
UA (1) UA61152C2 (no)
WO (1) WO2000018400A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196168A2 (en) * 1999-06-25 2002-04-17 Orion Corporation Method of admistering an imidazole derivative to obtain analgesia
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US5801188A (en) * 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement

Also Published As

Publication number Publication date
CZ299918B6 (cs) 2008-12-29
CA2345521C (en) 2009-05-05
DE69923698T2 (de) 2006-01-12
DK1117399T3 (da) 2005-03-29
DE69923698D1 (de) 2005-03-17
KR20010079860A (ko) 2001-08-22
AU5986099A (en) 2000-04-17
BG105469A (en) 2001-11-30
IL141680A0 (en) 2002-03-10
HU227634B1 (en) 2011-10-28
EA200100405A1 (ru) 2001-10-22
HUP0103864A2 (hu) 2002-05-29
HK1039751A1 (zh) 2002-05-10
EP1117399B1 (en) 2005-02-09
AU756104B2 (en) 2003-01-02
SK3812001A3 (en) 2002-02-05
CN1320034A (zh) 2001-10-31
NO20011545L (no) 2001-03-26
EP1117399A1 (en) 2001-07-25
IL141680A (en) 2007-06-17
KR100646811B1 (ko) 2006-11-17
EE200100193A (et) 2002-08-15
NO330436B1 (no) 2011-04-11
JP2002525324A (ja) 2002-08-13
NZ510233A (en) 2003-05-30
CZ2001933A3 (cs) 2001-08-15
CA2345521A1 (en) 2000-04-06
UA61152C2 (en) 2003-11-17
EA003216B1 (ru) 2003-02-27
PL346908A1 (en) 2002-03-11
US6495584B1 (en) 2002-12-17
JP4647785B2 (ja) 2011-03-09
HUP0103864A3 (en) 2002-08-28
WO2000018400A1 (en) 2000-04-06
ES2237205T3 (es) 2005-07-16
ATE288753T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
JPH06157301A (ja) トラマドール物質及び非ステロイド抗炎症薬を含んで成る組成物
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
JP2006213736A (ja) 鎮痛剤およびその使用
JP2006124380A (ja) 医薬組成物
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
MX2007006637A (es) Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa.
RU2010107843A (ru) Бупропиона гидробромид и его терапевтические применения
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
Darnobid The pharmacology of total intravenous anesthesia
WO1994016689A1 (en) Analgesic medicinal composition
HUP9901208A2 (hu) (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény
NO20011545D0 (no) Anvendelse av 3-(1H-imidazol-4-yl-metyl)-indan-5-ol til fremstilling av et legemiddel for intraspinal, intratekal eller epidural administrering
JP2009073851A (ja) ロキソプロフェン含有医薬製剤２
WO2007059445A3 (en) Synergistic combinations of norketamine and opioid analgesics
WO2005065372A3 (en) Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
ITMI20080798A1 (it) Composizione a rilascio modificato a base di doxofillina
MXPA04010658A (es) Tratamiento de dolor con ifenprodil.
Bruhn ESRA19-0716 Pain rebound in day surgery: how can we avoid it?
WO2001000192A3 (en) Method of administering an imidazole derivative to obtain analgesia
JP2006124381A (ja) 炎症の予防および／または治療薬
DE602007004018D1 (de) Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen
JP2004331660A (ja) 医薬組成物
Rorarius et al. The effect of diclofenac and ketoprofen on halothane MAC in rabbit

Legal Events

Date Code Title Description
MK1K Patent expired